Country: Malta
Language: English
Source: Medicines Authority
VALACICLOVIR
The Wellcome Foundation 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
J05AB11
VALACICLOVIR 500 mg
FILM-COATED TABLET
VALACICLOVIR 500 mg
POM
ANTIVIRALS FOR SYSTEMIC USE
Withdrawn
2005-06-04
(GSK LOGO) GLAXOSMITHKLINE PACKAGE LEAFLET: INFORMATION FOR THE USER VALTREX® 250 MG FILM-COATED TABLETS 500 MG FILM-COATED TABLETS VALACICLOVIR READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Valtrex is and what it is used for 2. What you need to know before you take Valtrex 3. How to take Valtrex 4. Possible side effects 5. How to store Valtrex 6. Contents of the pack and other information 1. WHAT VALTREX IS AND WHAT IT IS USED FOR Valtrex belongs to a group of medicines called antivirals. It works by killing or stopping the growth of viruses called herpes simplex (HSV), varicella zoster (VZV) and cytomegalovirus (CMV). Valtrex can be used to: • treat shingles (in adults) • treat HSV infections of the skin and genital herpes (in adults and adolescents over 12 years old). It is also used to help prevent these infections from returning. • treat cold sores (in adults and adolescents over 12 years old) • prevent infection with CMV after organ transplants (in adults and adolescents over 12 years old) • treat and prevent HSV infections of the eye that continue to come back (in adults and adolescents over 12 years old) 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE VALTREX Read the complete document
Page 1 of 14 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Valtrex 500 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains valaciclovir hydrochloride equivalent to 500 mg valaciclovir For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. 500 mg tablet White, biconvex, elongated tablet with a white to off-white core, engraved “GX CF1” on one side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _Varicella zoster virus (VZV) infections – herpes zoster _ _ _ Valtrex is indicated for the treatment of herpes zoster (shingles) and ophthalmic zoster in immunocompetent adults (see sections 4.4). Valtrex is indicated for the treatment of herpes zoster in adult patients with mild or moderate immunosuppression (see section 4.4). _Herpes simplex virus (HSV) infections _ Valtrex is indicated • for the treatment and suppression of HSV infections of the skin and mucous membranes including - treatment of first-episode of genital herpes in immunocompetent adults and adolescents and in immunocompromised adults - treatment of recurrences of genital herpes in immunocompetent adults and adolescents, and in immunocompromised adults - suppression of recurrent genital herpes in immunocompetent adults and adolescents and in immunocompromised adults • Treatment and suppression of recurrent ocular HSV infections in immunocompetent adults and adolescents and in immunocompromised adults (see section 4.4) Page 2 of 14 Clinical studies have not been conducted in HSV-infected patients immunocompromised for other causes than HIV-infection (see section 5.1). _ _ _Cytomegalovirus (CMV) infections_ : Valtrex is indicated for the prophylaxis of CMV infection and disease following solid organ transplantation in adults and adolescents (see section 4.4) 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Varicella zoster virus (VZV) infections – herpes zoster and ophthalmic zoster _ _ _ Patients should be advised to start treatment as soon as possibl Read the complete document